Identifying Undiagnosed Nonvalvular Atrial Fibrillation in the Age of Telehealth: Novel Screening Technologies and Stroke Prevention Strategies
Undetected atrial fibrillation (AF) can lead to a host of related negative sequelae (e.g., stroke, heart failure, and sudden death) that are often preventable with appropriate treatment. Join us as 2 prominent cardiology experts review data on digital tools that can help overcome barriers to AF care and strategies to prevent stroke once AF is detected, including risk assessment and shared decision-making to determine whether, and, if so, what type of oral anticoagulation is needed. This education is expected to enable identification and management of this serious condition promptly, consistently, and in accordance with the latest evidence.
Faculty
Christian T. Ruff, MD, MPH
Mintu Turakhia, MD, MS
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the high clinical impact of atrial fibrillation (AF), including the risk of stroke
- Implement evidence-based in-office and telehealth strategies for identification of undiagnosed AF
- Individualize oral anticoagulation decisions regarding stroke prevention in patients with nonvalvular AF (NVAF) based on guideline-recommended risk assessment, patient characteristics, and current evidence
Target Audience
This activity has been designed to address the educational needs of cardiologists, interventional cardiologists, primary care providers, allied healthcare professionals (ie, nurse practitioners, PAs, and pharmacists), and other clinicians involved in the care of patients with cardiovascular disease.
Identifying Undiagnosed Nonvalvular Atrial Fibrillation in the Age of Telehealth: Novel Screening Technologies and Stroke Prevention Strategies
6:00 pm - 7:15 pm